ארביטוקס - Erbitux

× ×ª×× × ×ª×¨××¤×

××¦××ª

××××¨××

××××¢ × ××¡×£

×¡×¨××× ××

××¨×¦×××ª

××××¨××

××¦×¤××× ×××××¢ ×××¨×× ××¨××¤××× ××© ××××× ×¡ ×××©××× ×. ×× ××× × ×¨×©×× ××× ×¡ ×××¨×©×× ××¨××¤××× ××× ×©× ××§×¦××¢××ª ×¨×¤×××××.

×××¡ ×¢×××ª-×ª××¢××ª ×©× ×¡×××§×¡×××× ××§× ×¨××©×× ××××¤×× ××¡×¨×× ×§××××¨×§××××

×©××× ××Â !
××ª×¨××¤× × ×¢××× ×:××××¨ ××ª×¨××¤××ª ×©× ××©×¨× ×××¨××××ª.
×× ××ª×§××× ××××¢× ×¢× ××¤×¡×§×ª ×©××××§ ××ª×¨××¤× ×:××¢×¨××ª ×××××¢××ª ×¢× ××¤×¡×§×ª ×©××××§ ×ª×¨××¤××ª.
×ª××¨×× ×¢×××× ×××¨×× ××ª×¨××¤× ×× ××××§××ª×¨××¤××ª ××× 02/10/15.

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

××× ×× ×× × ××¡×¤××

××¨×××××§×¡ 5 ×"×/×"× - Erbitux 5 mg/ml

×§×××¦× ×¤×¨××§××××××ª (ATC4)

L01FE
EGFR (Epidermal Growth Factor Receptor) inhibitors

××¨××× ×¤×¢×× (ATC5)

*Cetuximab 2MG/ML âL01FE01

×¦××¨×ª ××ª×

×ª××-××¨××× - I.V

×¦××¨×ª ××× ××

×ª×××¡× ×××× ×¤××××, SOLUTION FOR INFUSION
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Erbitux is indicated for the treatment of patients with KRAS wild-type metastatic colorectal cancerÂ : â¢ in combination with chemotherapy â¢ as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy or who are intolerant to irinotecan. Erbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck (SCCHN) â¢ in combination with radiation therapy for locally advanced disease â¢ in combination with platinum-based chemotherapy for recurrent and/or metastatic disease â¢ as a single agent after failure of platinum-based chemotherapy for recurrent and/or metastatic disease

× ×ª×× × ×¡× [ ××¦×× ]

××××××ª ××¡×

××ª×××× ××¡×

×ª××¨×× ××××× ××¡×

20/09/2006

××¡××¨×ª ××××× ××¡×

××ª×¨××¤× ×ª×× ×ª× ××××¤×× ×××§×¨×× ××××:
1. ××©×××× ×¢× ××§×¨× ××ª ××××¤×× ××¡×¨×× ×¨××© ×¦××××¨ ××ª×§×× ××§××× ××¡×× ×ª××× ×§×©×§×©××× (Squamous cell carcinoma of the head and neck - SCCHN)
2. ××©×××× ×¢× ×××××ª×¨×¤×× ×× ××ª××©××¨ ×××× ××××¤×× ××¡×¨×× ××¨××¨×ª× ×/×× ××××¨ ×©× ××¨××© ×××¦××××¨ ××¡×× ×ª××× ×§×©×§×©××× (SCCHN - Squamous cell carcinoma of the head and neck)
3. ××©×××× ×¢× ×××××ª×¨×¤×× ××××¤×× ××¡×¨×× ××¢× ××¡ ××¨××¨×ª× ××§× ×××¤×× ×¨××©×× ×× ××§× ×××¤×× ××ª×§×× (×©× × ×××××), ×¢×××¨ ××××× ×¢× ××××××× ××× ××××¦×× ×-KRAS
×§××× ××××× ×××¤×× ××××ª ×××ª×¨××¤××ª Cetuximab ×× Panitumumab, ×× ××§×× ×××¤×× ××ª×¨××¤× ××××¨×ª, ××××× ××
××××¤×× ××ª××©××¨ ××× ×ª× ××××× ×©××¨× ×××¤× ×-Cetuximab ××××× ××, ×××¢× ××××× ××¡×¨×× ××¢× ××¡ ×× ×¨×§××× ××¨××¨×ª×, ×××××¤× ××©×××× ×©× Cetuximab ×¢× Encorafenib, ××©×¨ ×§××× ×××¤×× ×§××× ×××××ª×, ××××× ××××¦×× ××¡×× BRAF V600E

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

Â ××× ×¢××× ××¨××¤× Â

×¢××× ××¦×¨××	Â

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
××¨×××××§×¡ ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	MERCK KGAA, GERMANY
×©× ××¢× ××¨××©××	MERCK SERONO LTD
×¨××©×××	×ª××¨×× ×××©×: 03/02/2005. ×¨××©××× ××ª××¨××: 31/05/2005
×ª××¨×× ×¢×××× ×××¨××	02/10/15

↑חזרה לקטע הקודם

ארביטוקס - Erbitux

× ×ª×× × ×¡× [ ××¦×× ]

ויקיתרופות

× ×ª×× × ×¡× [ ××¦×× ]